4DMedical Updates on Director’s Securities Interests

4DMedical Ltd (AU:4DX) has released an update.

4DMedical Ltd has announced a change in director John Livingston’s interest in securities, with the issuance of 60,147 options as part of his remuneration package. These options, valued at $36,250, were approved at the recent Annual General Meeting and add to his already significant holdings in the company. This update reflects the company’s commitment to aligning executive compensation with shareholder interests.

For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.